Vaccine maker got $1 billion from taxpayers. Now it's boosting drug prices
Monday, September 14, 2020 - 18:30
in Mathematics & Economics
AstraZeneca, which received U.S. funds to develop a COVID-19 vaccine, raised prices despite promises by President Trump to keep drug costs in check.